2015
DOI: 10.1161/circulationaha.115.016328
|View full text |Cite
|
Sign up to set email alerts
|

Expanding Saga of the Renin-Angiotensin System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 19 publications
0
11
0
Order By: Relevance
“…The activation of the renin-angiotensin-aldosterone (Aldo) system (RAAS) plays a pivotal role in patients with hypertension [1], diabetes and other progressive nephropathies [2,3] and may cause various physiological effects through both genomic and non-genomic mechanisms [4]. Although interruption of the RAAS by angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) significantly reduces morbidity and mortality [5,6] as well as the severity of proteinuria and nephrology in patients with chronic kidney disease (CKD) [7,8], Aldo concentrations 'escape' to baseline during longterm therapy [9].…”
Section: Introductionmentioning
confidence: 99%
“…The activation of the renin-angiotensin-aldosterone (Aldo) system (RAAS) plays a pivotal role in patients with hypertension [1], diabetes and other progressive nephropathies [2,3] and may cause various physiological effects through both genomic and non-genomic mechanisms [4]. Although interruption of the RAAS by angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) significantly reduces morbidity and mortality [5,6] as well as the severity of proteinuria and nephrology in patients with chronic kidney disease (CKD) [7,8], Aldo concentrations 'escape' to baseline during longterm therapy [9].…”
Section: Introductionmentioning
confidence: 99%
“…As a critical mediator of the RAAS, plasma and tissue Aldo levels are elevated in patients with hypertension (21), and diabetic and other progressive nephropathies (22,23), and may exert various physiological effects (24). Although interruption of the RAAS with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers significantly improves kidney injury, Aldo concentrations ‘escape’ to baseline during chronic therapy (25).…”
Section: Discussionmentioning
confidence: 99%
“…Renin release is regulated by an intrarenal baroreceptor that detects pressure in the afferent arteriole, by β-adrenergic sympathetic innervation and the delivery of salt (especially Cl) in the tubular fluid. 17 , 18 , 20 …”
Section: Renin-angiotensin Aldosterone System and Hypertensionmentioning
confidence: 99%